Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV A Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00466505
What this trial is testing

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colorectal Cancer
Vanderbilt-Ingram Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT01079780
What this trial is testing

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 136
Testing effectiveness (Phase 2)Ended earlyNCT03592641
What this trial is testing

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

Who this might be right for
Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+18 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT00031616
What this trial is testing

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
NewBiotics
Large-scale testing (Phase 3)Ended earlyNCT00077233
What this trial is testing

FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 238
Not applicableStudy completedNCT00280761
What this trial is testing

Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 47
Not applicableStudy completedNCT04597151
What this trial is testing

Diet Education Program for Stage I-IV Colorectal Cancer Survivors

Who this might be right for
Stage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8+10 more
University of California, San Francisco 13
Testing effectiveness (Phase 2)Looking for participantsNCT06820463
What this trial is testing

Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AbbVie 390
Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Not applicableStudy completedNCT01243372
What this trial is testing

Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,142
Not applicableStudy completedNCT05550701
What this trial is testing

Prognostic Impact of Increased Lymph Node Yield in Colorectal Cancer Patients With Synchronous Distant Metastasis: a Population-based Study of the US Database and a Chinese Registry

Who this might be right for
Colorectal Cancer Stage IVLymph Node Yield
The Second Affiliated Hospital of Harbin Medical University 4,575
Testing effectiveness (Phase 2)Study completedNCT00049101
What this trial is testing

Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Very early researchLooking for participantsNCT07050394
What this trial is testing

A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer RecurrentColorectal Cancer Stage IV
Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Early research (Phase 1)Active Not RecruitingNCT04535401
What this trial is testing

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Digestive System CarcinomaAdvanced Gastric Carcinoma+11 more
National Cancer Institute (NCI) 10
Early research (Phase 1)Study completedNCT00449137
What this trial is testing

Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment

Who this might be right for
Colorectal Cancer
University of Miami 13
Early research (Phase 1)Study completedNCT00006387
What this trial is testing

Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Fox Chase Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00003433
What this trial is testing

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Duke Cancer Institute
Early research (Phase 1)Study completedNCT00012155
What this trial is testing

Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Next Page